Cumberland Pharmaceuticals Inc.
Compositions and methods of treating cardiac fibrosis with ifetroban
Last updated:
Abstract:
The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
Status:
Grant
Type:
Utility
Filling date:
27 Jan 2020
Issue date:
23 Feb 2021